Deals
| Date | Target | Acquirer or investor | Type | Headline total |
|---|---|---|---|---|
| 16 July 2026 | AtaiBeckley Inc. | Eli Lilly and Company | acquisition | $3.8bn |
| 1 October 2025 | Gilgamesh Pharmaceuticals, Inc. | AbbVie Inc. | acquisition | $1.2bn |
| 2 June 2025 | Beckley Psytech Limited | atai Life Sciences N.V. (renamed Atai Beckley N.V. on completion) | acquisition | Not disclosed |